02.23.21

Asclepix Therapeutics Partners With Notal Vision on Home OCT Remote Monitoring in DME and AMD Clinical Trials

Source: Asclepix Therapeutics

02.16.21

Kodiak Sciences Announces 1-Year Data from Ongoing Phase 1b Study of KSI-301 in Patients with Retinal Vascular Diseases

Source: Kodiak Sciences

02.12.21

Genentech: New Phase 3 Data Show Faricimab the First Investigational Injectable Eye Medicine to Extend Time Between Treatment to Up to 4 Months

Source: Genentech

01.07.21

Adverum Biotechnologies Announces New GMP Gene Therapy Manufacturing Facility

Source: Adverum Biotechnologies

01.05.21

AsclepiX Therapeutics Doses First Patient in Phase 1/2a Trial of AXT107 Intravitreal Self-Forming Gel Depot Peptide for DME

Source: AsclepiX Therapeutics

12.21.20

Genentech’s Faricimab Meets Primary Endpoint and Shows Strong Durability Across Two Global Phase 3 Studies for DME

Source: Genentech

12.15.20

Novartis Reports Positive Topline Results From Second Phase 3 Trial of Beovu in Patients With DME

Source: Novartis

11.17.20

Fluocinolone Implant Real-World Experience Matches DME Trials

Source: Medscape

11.12.20

Kodiak Sciences Announces Presentation of KSI-301 Phase 1b Clinical Study Data Focused on DME at AAO 2020 Virtual Meeting

Source: Kodiak Sciences

11.09.20

Oxurion NV Confirms New Patents for THR-687 Issued by European and US Patent Offices

Source: Oxurion

View more stories